ArticleInfection and drug resistance2025
The Role of Yinqiao Powder in Modulating
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Piperonylpiperazine Targets RhlI to Reduce Virulence and Potentiate EDTA Sensitivity inFoods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: It is now understood that the primary challenges in treating Methods: First, the effects of Yinqiao Powder on various virulence factors of Results: This study revealed that sub-minimum inhibitory concentration (sub-MIC) levels of Yinqiao Powder significantly inhibit biofilm formation, swarming motility, pyocyanin and rhamnolipid production in a dose-dependent manner. The cytotoxicity assay also confirmed that Yinqiao Powder weakened the cytotoxicity of Conclusion: Yinqiao Powder effectively inhibits QS system-related regulatory genes, sRNAs, biofilm formation, swarming motility, pyocyanin and rhamnolipid production at specific concentrations. These results support the potential of Yinqiao Powder as a quorum-sensing inhibitor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.